The Current Ins and Outs of Cellular Therapies for Gastrointestinal Disease
Discover the classification of chronic inflammatory enteropathy and examine how regenerative medicine may contribute to disease management.
About the Webinar
This webinar will discuss the current information around the use of cellular therapies including mesenchymal stromal cell (MSC) therapy to treat chronic gastrointestinal disease (i.e. chronic inflammatory enteropathy (CIE), previously known as inflammatory bowel disease (IBD)). Attendees will gain an evidence-based understanding of the rationale, specific therapies and applications, opportunities, and challenges.
This program has been submitted for RACE approval (20-1378079) and is pending review for 1 hour of continuing education credit for veterinarians and veterinary technicians/technologists in jurisdictions that recognize RACE approval.
Learning objectives
- Describe the rationale for the application of cellular therapies to chronic gastrointestinal disease.
- Evaluate current veterinary studies investigating MSC therapies for chronic gastrointestinal disease in veterinary medicine.
- Assess future opportunities to apply cellular therapies for chronic gastrointestinal disease in veterinary patients.
Related reading
1. Regenerative Medicine in Veterinary Practice: Perceptions, Experience, and Outlook
2. From Autologous to Allogeneic: The Evolution of Stem Cell Therapies in Veterinary Medicine
Start Learning Now
Explore courses, grow your skills, and earn CE credits - all at your pace.
What our learners say about
growing their skills and reaching new goals.
About the presenter
Tracy Webb
Dr. Tracy Webb received her DVM degree from The Ohio State University, followed by a small animal medicine and surgery internship and emergency and critical care residency at Angell Animal Medical Center. Tracy then completed a PhD in Pathology (Immunology) at Colorado State University, where she is currently an Associate Professor in the Department of Clinical Sciences and manages veterinary and translational regulatory affairs in the Office of the Vice President for Research.
She is the lead for the Natural Animal Models Core of the Colorado Clinical and Translational Science Institute (CCTSI), a Distinguished Fellow in the National Academies of Practice, chair of the Clinical and Translational Science Award One Health Alliance (COHA) Communication and Collaboration subcommittee, past chair and on the Board of Directors of the North American Veterinary Regenerative Medicine Association (NAVRMA), and involved in various projects, committees, and initiatives to support and perform quality and sustainable veterinary research to improve patient outcomes.
Continue Learning
See all
Neuroinflammatory Pathways among Common Neurological Diseases: Targets for Stem Cell Therapy
Understand the mechanisms and potential of stem cells in treating complex neurological conditions in dogs and cats.
Current Evidence for Regenerative Medicine in Canine and Feline Osteoarthritis
Discover the biology and immunology of osteoarthritis and gain practical guidance on using regenerative medicine for early intervention.
You Asked, We Answered: Common Questions about Mesenchymal Stromal Cell Therapy
Get science-backed answers to the most commonly asked questions about the future of stem cell therapy in veterinary medicine.
